According to the research report, the global central lab market size is expected to touch USD 3,841.12 million by 2027, from USD 2,847.87 million in 2022, growing with a significant CAGR of 6.2%.
The central lab report offers a
comprehensive study of the current state expected at the major drivers, market
strategies, and key vendors’ growth. The report presents energetic visions to
conclude and study the market size, market hopes, and competitive surroundings.
The research also focuses on the important achievements of the market, research
& development, and regional growth of the leading competitors operating in
the market. The current trends of the global central lab in conjunction with
the geographical landscape of this vertical have also been included in this
report.
The report offers intricate dynamics about
different aspects of the global central lab market, which aids companies
operating in the market in making strategic development decisions. The study
also elaborates on significant changes that are highly anticipated to configure
growth of the global central lab during the forecast period. It also includes a
key indicator assessment that highlights growth prospects of this market and
estimates statistics related to growth of the market in terms of value (US$ Mn)
and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/1556
This study covers a detailed segmentation
of the global central lab market, along with key information and a competition
outlook. The report mentions company profiles of players that are currently
dominating the global central lab market, wherein various developments,
expansions, and winning strategies practiced and implemented by leading players
have been presented in detail.
Key Players
- ACM Global Central Lab
- Barc Lab (Cerba Research)
- Bioscientia (Sonic Healthcare)
- Celerion
- CIRION BioPharma Research
- Clinical Reference Laboratory
- Lab Corp
- Eurofins Central Laboratory
- Frontage Laboratories, Inc
- icon central labs
- INTERLAB Central Lab Services
- LabConnect
- Medpace
Market Segmentation
- Genetic Services
- Biomarker Services
- Microbiology Services
- Anatomic Pathology/Histology
- Specimen Management & Storage
- Special Chemistry Services
- Clinical Research & Trial Services
- Others
By End User
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Institutes
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Research Methodology
The research methodology adopted by
analysts for compiling the global central lab report is based on detailed
primary as well as secondary research. With the help of in-depth insights of
the market-affiliated information that is obtained and legitimated by
market-admissible resources, analysts have offered riveting observations and authentic
forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global central lab market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Central Lab Market
5.1. COVID-19 Landscape: Central Lab Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Central Lab Market, By Product
8.1. Central Lab Market, by Product Type, 2021-2027
8.1.1. Genetic Services
8.1.1.1. Market Revenue and Forecast (2019-2027)
8.1.2. Biomarker Services
8.1.2.1. Market Revenue and Forecast (2019-2027)
8.1.3. Microbiology Services
8.1.3.1. Market Revenue and Forecast (2019-2027)
8.1.4. Anatomic Pathology/Histology
8.1.4.1. Market Revenue and Forecast (2019-2027)
8.1.5. Specimen Management & Storage
8.1.5.1. Market Revenue and Forecast (2019-2027)
8.1.6. Special Chemistry Services
8.1.6.1. Market Revenue and Forecast (2019-2027)
8.1.7. Clinical Research & Trial Services
8.1.7.1. Market Revenue and Forecast (2019-2027)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2019-2027)
Chapter 9. Global Central Lab Market, By Application
9.1. Central Lab Market, by Application, 2021-2027
9.1.1. Pharmaceutical Companies
9.1.1.1. Market Revenue and Forecast (2019-2027)
9.1.2. Biotechnology Companies
9.1.2.1. Market Revenue and Forecast (2019-2027)
9.1.3. Academic & Research Institutes
9.1.3.1. Market Revenue and Forecast (2019-2027)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2019-2027)
Chapter 10. Global Central Lab Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2019-2027)
10.1.2. Market Revenue and Forecast, by Application (2019-2027)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product (2019-2027)
10.1.3.2. Market Revenue and Forecast, by Application (2019-2027)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product (2019-2027)
10.1.4.2. Market Revenue and Forecast, by Application (2019-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2019-2027)
10.2.2. Market Revenue and Forecast, by Application (2019-2027)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product (2019-2027)
10.2.3.2. Market Revenue and Forecast, by Application (2019-2027)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product (2019-2027)
10.2.4.2. Market Revenue and Forecast, by Application (2019-2027)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product (2019-2027)
10.2.5.2. Market Revenue and Forecast, by Application (2019-2027)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product (2019-2027)
10.2.6.2. Market Revenue and Forecast, by Application (2019-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2019-2027)
10.3.2. Market Revenue and Forecast, by Application (2019-2027)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product (2019-2027)
10.3.3.2. Market Revenue and Forecast, by Application (2019-2027)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product (2019-2027)
10.3.4.2. Market Revenue and Forecast, by Application (2019-2027)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product (2019-2027)
10.3.5.2. Market Revenue and Forecast, by Application (2019-2027)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product (2019-2027)
10.3.6.2. Market Revenue and Forecast, by Application (2019-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2019-2027)
10.4.2. Market Revenue and Forecast, by Application (2019-2027)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product (2019-2027)
10.4.3.2. Market Revenue and Forecast, by Application (2019-2027)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product (2019-2027)
10.4.4.2. Market Revenue and Forecast, by Application (2019-2027)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product (2019-2027)
10.4.5.2. Market Revenue and Forecast, by Application (2019-2027)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product (2019-2027)
10.4.6.2. Market Revenue and Forecast, by Application (2019-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2019-2027)
10.5.2. Market Revenue and Forecast, by Application (2019-2027)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product (2019-2027)
10.5.3.2. Market Revenue and Forecast, by Application (2019-2027)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product (2019-2027)
10.5.4.2. Market Revenue and Forecast, by Application (2019-2027)
Chapter 11. Company Profiles
11.1. ACM Global Central Lab
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Barc Lab (Cerba Research)
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Bioscientia (Sonic Healthcare)
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Celerion
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. CIRION BioPharma Research
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Clinical Reference Laboratory
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Lab Corp
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Eurofins Central Laboratory
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Frontage Laboratories, Inc
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. icon central labs
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments